These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8513007)

  • 1. Isolation and identification of canine plasma components suspected as uremic toxins.
    Kawamura M; Ohashi F; Nagata Y; Takai N; Motoie H; Nishimura R; Sasaki N; Takeuchi A
    J Vet Med Sci; 1993 Apr; 55(2):265-70. PubMed ID: 8513007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of uremic peaks in dogs by anion exchange high performance liquid chromatography.
    Kawamura M; Ohashi F; Murakami F; Takai N; Nishimura R; Sasaki N; Takeuchi A
    J Vet Med Sci; 1992 Oct; 54(5):951-5. PubMed ID: 1420578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Separation of six uremic middle molecular compounds by high performance liquid chromatography and analysis by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Chu J; Yuan Z; Liu X; Wu Q; Mi H; He B
    Clin Chim Acta; 2001 Sep; 311(2):95-107. PubMed ID: 11566169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A compound from uremic plasma and from normal urine isolated by liquid chromatography and identified by nuclear magnetic resonance.
    Gallice P; Monti JP; Crevat A; Durand C; Murisasco A
    Clin Chem; 1985 Jan; 31(1):30-4. PubMed ID: 3965216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma concentrations of substances suspected as uremic toxins in experimentally induced and spontaneous uremic dogs.
    Kawamura M; Ohashi F; Nishimura R; Sasaki N; Takeuchi A
    J Vet Med Sci; 1994 Apr; 56(2):381-3. PubMed ID: 8075231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technical aspects on middle molecules: separation, isolation, and identification.
    Cueille G; Man NK; Sausse A; Farges JP; Funck-Brentano JL
    Artif Organs; 1981; 4 Suppl():8-12. PubMed ID: 7295100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ascorbic acid derivatives in two different fractions of uremic toxins.
    Gallice PM; Monti JP; Braguer DL; Baz M; Elsen RE; Berland YF; Crevat AD
    Int J Artif Organs; 1991 Dec; 14(12):754-8. PubMed ID: 1783448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of plasma middle molecular fraction in uremic patients.
    Kovalishin YaF
    Biomater Artif Cells Artif Organs; 1987; 15(3):605-10. PubMed ID: 3440134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uremic middle molecules: analytical study of middle molecular weight fractions subpeak b4-2.
    Le Moel G; Strecker G; Cueille G; Boudet J; Man NK; Galli A; Agneray J
    Artif Organs; 1981; 4 Suppl():17-21. PubMed ID: 7295087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separation, identification of uremic middle molecules, and preliminary study on their toxicity.
    Li G; Chu J; Liu X; Yuan Z
    Clin Chim Acta; 2004 Dec; 350(1-2):89-98. PubMed ID: 15530464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous determination of serum uremic toxins, cations and anions and urea determination by post-column colorimetry using immobilized enzyme.
    Shintani H
    J Chromatogr; 1986 May; 378(1):95-108. PubMed ID: 3733986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of inhibitors of ligand: albumin-binding from uremic body fluids and normal urine.
    Gulyassy PF; Bottini AT; Jarrard EA; Stanfel LA
    Kidney Int Suppl; 1983 Dec; 16():S238-42. PubMed ID: 6588258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ion-pair high-performance liquid chromatography profiling of a uremic toxin fraction.
    Gallice P; Monti JP; Le Gall JM; Crevat A; Murisasco A
    J Chromatogr; 1987 Nov; 422():263-6. PubMed ID: 3437013
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of two uremic toxins by nuclear magnetic resonance and mass spectrometry.
    Monti JP; Gallice P; Braguer D; Durand C; Murisasco A; Crevat A
    Adv Exp Med Biol; 1987; 223():223-6. PubMed ID: 3447439
    [No Abstract]   [Full Text] [Related]  

  • 15. Search for peptidic "middle molecules" in uremic sera: isolation and chemical identification of fibrinogen fragments.
    Kaplan B; Cojocaru M; Unsworth E; Knecht A; Martin BM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Oct; 796(1):141-53. PubMed ID: 14552825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Separation, isolation and amino acid composition of uremic peptides.
    Shaykh M; Dubin A; Dunea G; Mamdani B; Ahmed S
    Clin Physiol Biochem; 1984; 2(1):1-13. PubMed ID: 6488692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uremic toxins and the elusive middle molecules.
    Schoots A; Mikkers F; Cramers C; de Smet R; Ringoir S
    Nephron; 1984; 38(1):1-8. PubMed ID: 6472528
    [No Abstract]   [Full Text] [Related]  

  • 18. Analytical study for separation of middle molecules.
    Saito A; Kanazawa I; Chung TG; Maeda K
    Artif Organs; 1981; 4 Suppl():13-6. PubMed ID: 6975092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of endogenous middle molecules in normal and uremic body fluids.
    Fürst P; Zimmerman L; Bergström J
    Clin Nephrol; 1976 Apr; 3(2):178-88. PubMed ID: 1277595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of middle molecular weight fraction in the plasma of patients with uremia using high performance liquid chromatography and thin layer chromatography].
    Kovalishin IaF; Nikolaev VG; Baran EIa; Dudar' IA; Iushko LA
    Vopr Med Khim; 1988; 34(6):23-6. PubMed ID: 3238937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.